Chronic Illness

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by King, C. H.
Right arrow Articles by Dangerfield-Cha, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, C. H.
Right arrow Articles by Dangerfield-Cha, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Chronic Illness, Vol. 4, No. 1, 65-79 (2008)
DOI: 10.1177/1742395307084407
© 2008 SAGE Publications

The unacknowledged impact of chronic schistosomiasis

Charles H. King

Center for Global Health and Diseases, Case Western Reserve University School of Medicine 10900 Euclid Avenue, Cleveland, Ohio 44106-7286, USA, chk{at}cwru.edu

Madeline Dangerfield-Cha

Columbia University, New York, NY 10027, USA

Objectives: To summarize new knowledge on the range of disease due to chronic schistosomiasis and examine the debilitating burden of both light and heavy infection; to outline goals of disease prevention, including current age-targeted strategies and more extended programmes aimed at preventing transmission.

Methods: A systematic search of 2004—2007 papers via PUBMED and related databases using `schistosom' and disability- or treatment-related subject headings. Reports were independently reviewed for inclusion.

Results: Sixty-eight papers met review objectives. These suggest new evidence for a causative link between schistosome infection, antiparasite inflammation, and risk for anaemia, growth stunting and undernutrition in affected populations, as well as exacerbation of co-infections and impairment of cognitive development and work capacity. Formal quality-of-life assessment defines a significant 9.5—24% disability with the most aggressive schistosome species, Schistosoma japonicum.

Discussion: Schistosomiasis represents a serious but under-recognized disease burden for many developing countries. Infection (and not intensity of infection) should be considered the defining feature of morbidity formation. Links between infection and long-term disabilities reduce the chances of combating rural poverty. Changes in our appreciation of schistosomiasis-related disease burden means it is no longer appropriate to leave infected persons untreated, and newer approaches to control should focus on preventing transmission.

Key Words: Burden of illness • Developmental disabilities • Parasitic diseases • Quality-of-life • Schistosomiasis

References

  • Engels D., Savioli L. Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol 2006; 22: 363—6.[CrossRef][Medline] [Order article via Infotrieve]
  • Hotez PJ, Ferris MT The antipoverty vaccines. Vaccine 2006; 24: 5787—99.[CrossRef][Medline] [Order article via Infotrieve]
  • Ukwandu NC, Nmorsi OP The perception, beliefs and practices toward genitourinary schistosomiasis by inhabitants of selected endemic areas (Edo/Delta States) in south-eastern Nigeria. Rev Inst Med Trop Sao Paulo 2004; 46: 209—16.[Medline] [Order article via Infotrieve]
  • de Vlas SJ, Danso-Appiah A., van der Werf MJ, Bosompem KM, Habbema JD Quantitative evaluation of integrated schistosomiasis control. Trop Med Int Health 2004; 9: A16—21.[Medline] [Order article via Infotrieve]
  • Danso-Appiah A., De Vlas SJ, Bosompem KM, Habbema JD Determinants of health-seeking behaviour for schistosomiasis-related symptoms in the context of integrating schistosomiasis control within the regular health services in Ghana. Trop Med Int Health 2004; 9: 784—94.[CrossRef][Medline] [Order article via Infotrieve]
  • Satayathum SA, Muchiri EM, Ouma JH, Whalen CC, King CH Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program. Am J Trop Med Hyg 2006; 75: 83—92.[Abstract/Free Full Text]
  • Amazigo UO, Anago-Amanze CI, Okeibunor JC Urinary schistosomiasis among school children in Nigeria: consequences of indigenous beliefs and water contact activities. J Biosoc Sci 1997; 29: 9—18.[CrossRef][Medline] [Order article via Infotrieve]
  • Mekheimar SI, Talaat M. School non-enrollment and its relation with health and schistosomiasis knowledge, attitudes and practices in rural Egypt. East Mediterr Health J 2005; 11: 392—401.[Medline] [Order article via Infotrieve]
  • King CH, Dickman K., Tisch DJ Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005; 365: 1561—9.[CrossRef][Medline] [Order article via Infotrieve]
  • Wilson RA, van Dam GJ, Kariuki TM, Farah IO, Deelder AM, Coulson PS The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates. Int J Parasitol 2006; 36: 1241—4.[CrossRef][Medline] [Order article via Infotrieve]
  • King CH Lifting the burden of schistosomiasis — defining elements of infection-associated disease and the benefits of anti-parasite treatment. J Infect Dis 2007; 196: 653—55.[CrossRef][Medline] [Order article via Infotrieve]
  • Kirigia JM Economic evaluation in schistosomiasis: valuation of health states preferences. A research note. Health Econ 1998; 7: 551—6.[CrossRef][Medline] [Order article via Infotrieve]
  • Parker M. Re-assessing disability: the impact of schistosomal infection on daily activities among women in Gezira Province, Sudan. Soc Sci Med 1992; 35: 877—90.[CrossRef][Medline] [Order article via Infotrieve]
  • World Health Organization. The control of schistosomiasis: Second Report of the WHO Expert Committee, Vol. 830. WHO Technical Report. Geneva: WHO, 1993.
  • Savioli L., Renganathan E., Montresor A., Davis A., Behbehani K. Control of schistosomiasis — a global picture. Parasitol Today 1997; 13: 444—8.[CrossRef][Medline] [Order article via Infotrieve]
  • Engels D., Chitsulo L., Montresor A., Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 2002; 82: 139—46.[CrossRef][Medline] [Order article via Infotrieve]
  • Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6: 411—25.[CrossRef][Medline] [Order article via Infotrieve]
  • World Health Organization. Public health impact of schistosomiasis: disease and mortality. WHO Expert Committee on the Control of Schistosomiasis. Bull WHO 1993; 71: 657—62.[Medline] [Order article via Infotrieve]
  • King CH Epidemiology of schistosomiasis: determinants of transmission of infection. In: Mahmoud AAF, ed. Schistosomiasis., London: Imperial College Press, 2001: 115—32.
  • Anderson RM, May RM Infectious diseases of humans. Dynamics and control. New York: Oxford University Press, 1991.
  • Smith JH, Christie JD The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 1986; 17: 333—45.[CrossRef][Medline] [Order article via Infotrieve]
  • Warren KS The pathology, pathobiology and pathogenesis of schistosomiasis. Nature 1978; 273: 609—12.[CrossRef][Medline] [Order article via Infotrieve]
  • Chen MG, Mott KE Progress in assessment of morbidity due to Schistosoma haematobium infection. Trop Dis Bull 1989; 86: R1—36.
  • Sturrock RF The schistosomes and their intermediate hosts. In: Mahmoud AAF, ed. Schistosomiasis, London: Imperial College Press, 2001: 7—83.
  • Warren KS Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis. Rev Infect Dis 1982; 4: 715—26.
  • World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: Report of a WHO expert committee. Technical Report Series 912. Report No. 912. Geneva: WHO, 2002.
  • Ezeamama AE, Friedman JF, Acosta LP, et al. Helminth infection and cognitive impairment among Filipino children. Am J Trop Med Hyg 2005; 72: 540—8.[Abstract/Free Full Text]
  • Coutinho HM, McGarvey ST, Acosta LP, et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 2005; 192: 528—36.[CrossRef][Medline] [Order article via Infotrieve]
  • Latham MC, Stephenson LS, Kurz KM, Kinoti SN Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections. Am J Trop Med Hyg 1990; 43: 170—9.[Abstract/Free Full Text]
  • Gryseels B. The relevance of schistosomiasis for public health. Trop Med Parasitol 1989; 40: 134—42.[Medline] [Order article via Infotrieve]
  • King CH, Sturrock RF, Kariuki HC, Hamburger J. Transmission control for schistosomiasis—why it matters now. Trends Parasitol 2006; 22: 575—82.[CrossRef][Medline] [Order article via Infotrieve]
  • Tanner M. Evaluation of public health impact of schistosomiasis. Trop Med Parasitol 1989; 40: 143—8.[Medline] [Order article via Infotrieve]
  • World Health Organization. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: WHO, 2006.
  • Warren KS, Mahmoud AAF. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians 1976; 89: 195—204.[Medline] [Order article via Infotrieve]
  • Fenwick A. New initiatives against Africa's worms. Trans R Soc Trop Med Hyg 2006; 100: 200—7.[CrossRef][Medline] [Order article via Infotrieve]
  • Ezeamama AE, Friedman JF, Olveda RM, et al. Functional significance of low-intensity polyparasite helminth infections in anemia. J Infect Dis 2005; 192: 2160—70.[CrossRef][Medline] [Order article via Infotrieve]
  • Kanzaria HK, Acosta LP, Langdon GC, et al. Schistosoma japonicum and occult blood loss in endemic villages in Leyte, the Philippines. Am J Trop Med Hyg 2005; 72: 115—18.[Abstract/Free Full Text]
  • Ajanga A., Lwambo NJ, Blair L., Nyandindi U., Fenwick A., Brooker S. Schistosoma mansoni in pregnancy and associations with anaemia in north-west Tanzania. Trans R Soc Trop Med Hyg 2006; 100: 59—63.[CrossRef][Medline] [Order article via Infotrieve]
  • Ayoya MA, Spiekermann-Brouwer GM, Traore AK, Stoltzfus RJ, Garza C. Determinants of anemia among pregnant women in Mali. Food Nutr Bull 2006; 27: 3—11.[Medline] [Order article via Infotrieve]
  • Brito LL, Barreto ML, de Silva RC, et al. Moderate- and low-intensity co-infections by intestinal helminths and Schistosoma mansoni, dietary iron intake, and anemia in Brazilian children. Am J Trop Med Hyg 2006; 75: 939—44.[Abstract/Free Full Text]
  • Koukounari A., Fenwick A., Whawell S., et al. Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am J Trop Med Hyg 2006; 75: 278—86.[Abstract/Free Full Text]
  • Leenstra T., Acosta LP, Langdon GC, et al. Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1. Am J Clin Nutr 2006; 83: 371—9.[Abstract/Free Full Text]
  • Leenstra T., Coutinho HM, Acosta LP, et al. Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation. Infect Immun 2006; 74: 6398—407.[Abstract/Free Full Text]
  • Koukounari A., Gabrielli AF, Toure S., et al. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 2007; 196: 659—69.[CrossRef][Medline] [Order article via Infotrieve]
  • Coutinho HM, Leenstra T., Acosta LP, et al. Higher serum concentrations of DHEAS predict improved nutritional status in helminth-infected children, adolescents, and young adults in Leyte, the Philippines. J Nutr 2007; 137: 433—9.[Abstract/Free Full Text]
  • Friedman JF, Kanzaria HK, Acosta LP, et al. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 2005; 72: 527—33.[Abstract/Free Full Text]
  • Friedman JF, Kanzaria HK, McGarvey ST Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005; 21: 386—92.[CrossRef][Medline] [Order article via Infotrieve]
  • Stoltzfus RJ, Kvalsvig JD, Chwaya HM, et al. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ 2001; 323: 1389—93.[Abstract/Free Full Text]
  • Taylor M., Jinabhai CC, Couper I., Kleinschmidt I., Jogessar VB The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial. Trans R Soc Trop Med Hyg 2001; 95: 211—16.[CrossRef][Medline] [Order article via Infotrieve]
  • Zhou H., Ohtsuka R., He Y., Yuan L., Yamauchi T., Sleigh AC Impact of parasitic infections and dietary intake on child growth in the schistosomiasis-endemic Dongting Lake Region, China. Am J Trop Med Hyg 2005; 72: 534—9.[Abstract/Free Full Text]
  • Guyatt H. Do intestinal nematodes affect productivity in adulthood?. Parasitol Today 2000; 16: 153—8.[CrossRef][Medline] [Order article via Infotrieve]
  • Zhou H., He Y., Ohtsuka R. Sex differences in the malnourished status of Chinese children due to schistosomiasis infections and inadequate dietary intake. Environ Sci 2005; 12: 145—53.[Medline] [Order article via Infotrieve]
  • Olds GR, King CH, Hewlett J., et al. Double-blind placebo controlled study of concurrent administration of albendazole and praziquantel in school children with schistosomiasis and geohelminths. J Infect Dis 1999; 179: 996—1003.[CrossRef][Medline] [Order article via Infotrieve]
  • Coutinho HM, Acosta LP, Wu HW, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 2007; 195: 288—95.[CrossRef][Medline] [Order article via Infotrieve]
  • Assis AM, Prado MS, Barreto ML, et al. Childhood stunting in Northeast Brazil: the role of Schistosoma mansoni infection and inadequate dietary intake. Eur J Clin Nutr 2004; 58: 1022—9.[CrossRef][Medline] [Order article via Infotrieve]
  • Zhou H., Watanabe C., Ohtsuka R. Impacts of dietary intake and helminth infection on diversity in growth among schoolchildren in rural south China: a four-year longitudinal study. Am J Hum Biol 2007; 19: 96—106.[CrossRef][Medline] [Order article via Infotrieve]
  • Bosompem KM, Bentum IA, Otchere J., et al. Infant schistosomiasis in Ghana: a survey in an irrigation community. Trop Med Int Health 2004; 9: 917—22.[CrossRef][Medline] [Order article via Infotrieve]
  • Stothard JR, Gabrielli AF Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol 2007; 23: 83—6.[CrossRef][Medline] [Order article via Infotrieve]
  • Hall A. Micronutrient supplements for children after deworming. Lancet Infect Dis 2007; 7: 297—302.[CrossRef][Medline] [Order article via Infotrieve]
  • Wamachi AN, Mayadev JS, Mungai PL, et al. Increased ratio of tumor necrosis factor-alpha to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidity. J Infect Dis 2004; 190: 2020—30.[CrossRef][Medline] [Order article via Infotrieve]
  • Jordan P., Webbe G. Epidemiology. In: Jordan P, Webbe G, Sturrock RF, eds. Human schistosomiasis. Wallingford, UK: CAB International, 1993: 87—158.
  • King CL, Malhotra I., Mungai P., et al. Schistosoma haematobium-induced urinary tract morbidity correlates with increased tumor necrosis factor-alpha and diminished interleukin-10 production. J Infect Dis 2001; 184: 1176—82.[CrossRef][Medline] [Order article via Infotrieve]
  • King CL Initiation and regulation of disease in schistosomiasis. In: Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press, 2001: 213—64.
  • Hagan P., Blumenthal UJ, Dunne D., Simpson AJG, Wilkins HA Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349: 243—5.[CrossRef][Medline] [Order article via Infotrieve]
  • Malhotra I., Mungai P., Wamachi A., et al. Helminth-and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162: 6843—8.[Abstract/Free Full Text]
  • Malhotra I., Mungai PL, Wamachi AN, et al. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J Infect Dis 2006; 193: 1005—13.[CrossRef][Medline] [Order article via Infotrieve]
  • Gallagher M., Malhotra I., Mungai PL, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005; 19:1849—55.[Medline] [Order article via Infotrieve]
  • Molyneux DH, Hotez PJ, Fenwick A. `Rapidimpact interventions': how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2005; 2: e336.[CrossRef][Medline] [Order article via Infotrieve]
  • Brown M., Miiro G., Nkurunziza P., et al. Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am J Trop Med Hyg 2006; 74: 819—25.[Abstract/Free Full Text]
  • El-Awady MK, Youssef SS, Omran MH, Tabll AA, El Garf WT, Salem AM Soluble egg antigen of Schistosoma haematobium induces HCV replication in PBMC from patients with chronic HCV infection. BMC Infect Dis 2006; 6: 91.[CrossRef][Medline] [Order article via Infotrieve]
  • Kallestrup P., Zinyama R., Gomo E., et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis 2005; 192: 1956—61.[CrossRef][Medline] [Order article via Infotrieve]
  • Lyke KE, Dicko A., Dabo A., et al. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg 2005; 73: 1124—30.[Abstract/Free Full Text]
  • Sokhna C., Le Hesran JY, Mbaye PA, et al. Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar J 2004; 3: 43.[CrossRef][Medline] [Order article via Infotrieve]
  • Kamal SM, Turner B., He Q., et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006; 43: 771—9.[CrossRef][Medline] [Order article via Infotrieve]
  • Raso G., Vounatsou P., Gosoniu L., Tanner M., N'Goran EK, Utzinger J. Risk factors and spatial patterns of hookworm infection among schoolchildren in a rural area of western Cote d'Ivoire. Int J Parasitol 2006; 36: 201—10.[CrossRef][Medline] [Order article via Infotrieve]
  • Fenwick A., Molyneux D., Nantulya V. Achieving the Millennium development goals. Lancet 2005; 365: 1029—30.[Medline] [Order article via Infotrieve]
  • Sachs JD The end of poverty, New York: Penguin Press, 2005.
  • Poggensee G., Feldmeier H., Krantz I. Schistosomiasis of the female genital tract: public health aspects. Parasitol Today 1999; 15: 378—81.[CrossRef][Medline] [Order article via Infotrieve]
  • Inhorn MC, van Balen F, eds. Infertility around the globe: new thinking on childlessness, gender, and reproductive technologies. Berkeley: University of California Press, 2002.
  • Vilana R., Corachan M., Gascon J., Valls E., Bru C. Schistosomiasis of the male genital tract: transrectal sonographic findings. J Urol 1997; 158: 1491—3.[CrossRef][Medline] [Order article via Infotrieve]
  • Feldmeier H., Leutscher P., Poggensee G., Harms G. Male genital schistosomiasis and haemospermia. Trop Med Int Health 1999; 4: 791—3.[CrossRef][Medline] [Order article via Infotrieve]
  • Kjetland EF, Ndhlovu PD, Mduluza T., et al. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 2005; 72: 311—19.[Abstract/Free Full Text]
  • Leutscher P., Ravaoalimalala VE, Raharisolo C., et al. Clinical findings in female genital schistosomiasis in Madagascar. Trop Med Int Health 1998; 3: 327—32.[CrossRef][Medline] [Order article via Infotrieve]
  • Bullough CH Infertility and bilharziasis of the female genital tract. Br J Obstet Gynaecol 1976; 83: 819—22.[Medline] [Order article via Infotrieve]
  • Swai B., Poggensee G., Mtweve S., Krantz I. Female genital schistosomiasis as evidence of a neglected cause for reproductive ill-health: a retrospective histopathological study from Tanzania. BMC Infect Dis 2006; 6: 134.[CrossRef][Medline] [Order article via Infotrieve]
  • AbouZahr C., Vaughan JP Assessing the burden of sexual and reproductive ill-health: questions regarding the use of disability-adjusted life years. Bull WHO 2000; 78: 655—66.[Medline] [Order article via Infotrieve]
  • Murray CJL, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health, 1996..
  • Guerrant RL, Kosek M., Lima AA, Lorntz B., Guyatt HL Updating the DALYs for diarrhoeal disease. Trends Parasitol 2002; 18: 191—3.[CrossRef][Medline] [Order article via Infotrieve]
  • Reidpath DD, Allotey PA, Kouame A., Cummins RA Measuring health in a vacuum: examining the disability weight of the DALY. Health Policy Plan 2003; 18: 351—6.[Abstract/Free Full Text]
  • Anand S., Hanson K. Disability-adjusted life years: a critical review. J Health Econ 1997; 16: 685—702.[CrossRef][Medline] [Order article via Infotrieve]
  • Finkelstein JL, McGarvey ST, Schleinitz MD Re-investigating the global burden of disease due to Schistosoma japonicum. Am J Trop Med Hyg 2005; 73: abstract 1038.[Abstract/Free Full Text]
  • Jia T-W., Zhou X-N., Wang X-H., Utzinger J., Steinmann P., Wu X-H. Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull WHO 2007; 85: 458—65.[CrossRef][Medline] [Order article via Infotrieve]
  • Yuan LP, Manderson L., Ren MY, Li GP, Yu DB, Fang JC School-based interventions to enhance knowledge and improve case management of schistosomiasis: a case study from Hunan, China. Acta Trop 2005; 96: 248—54.[CrossRef][Medline] [Order article via Infotrieve]
  • King CH Long-term outcomes of school-based treatment for control of urinary schistosomiasis: a review of experience in Coast Province, Kenya. Mem Inst Oswaldo Cruz 2006; 101: 299—306.[Medline] [Order article via Infotrieve]
  • Utzinger J., Zhou XN, Chen MG, Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop 2005; 96: 69—96.[CrossRef][Medline] [Order article via Infotrieve]
  • Liang S., Yang C., Zhong B., Qiu D. Re-emerging schistosomiasis in hilly and mountainous areas of Sichuan, China. Bull WHO 2006; 84: 139—44.[CrossRef][Medline] [Order article via Infotrieve]
  • King CH, Lombardi G., Lombardi C., et al. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 1988; 39: 295—305.[Abstract/Free Full Text]
  • Muchiri EM, Ouma JH, King CH Dynamics and control of Schistosoma haematobium transmission in Kenya: an overview of the Msambweni Project. Am J Trop Med Hyg 1996; 55: 127—34.[Medline] [Order article via Infotrieve]
  • Woolhouse ME, Etard JF, Dietz K., Ndhlovu PD, Chandiwana SK Heterogeneities in schistosome transmission dynamics and control. Parasitology 1998; 117: 475—82.
  • Hussein MH, Talaat M., El-Sayed MK, El-Badawi A., Evans DB Who misses out with school-based health programmes? A study of schistosomiasis control in Egypt. Trans R Soc Trop Med Hyg 1996; 90: 362—5.[CrossRef][Medline] [Order article via Infotrieve]
  • Talaat M., Omar M., Evans D. Developing strategies to control schistosomiasis morbidity in nonenrolled school-age children: experience from Egypt. Trop Med Int Health 1999; 4: 551—6.[CrossRef][Medline] [Order article via Infotrieve]
  • King CH, Muchiri E., Ouma JH, Koech D. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 1991; 45: 498—508.[Abstract/Free Full Text]
  • Centers for Disease Control. Schistosomiasis among river rafters—Ethiopia. MMWR 1983; 32: 585—6.[Medline] [Order article via Infotrieve]
  • Vercruysse J., Southgate VR, Rollinson D., et al. Studies on transmission and schistosome interactions in Senegal, Mali and Zambia. Trop Geogr Med 1994; 46: 220—6.[Medline] [Order article via Infotrieve]
  • Mubila L., Rollinson D. Snail—parasite compatibility and prevalence of Schistosoma haematobium on the shores of Lake Kariba, Zambia. Ann Trop Med Parasitol 2002; 96: 165—73.[CrossRef][Medline] [Order article via Infotrieve]
  • Sturrock RF Schistosomiasis epidemiology and control: how did we get here and where should we go?. Mem Inst Oswaldo Cruz 2001; 96Suppl: 17—27.
  • Bridges J., Stewart M., King M., van Gool K. Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies. Eur J Health Econ 2002; 3: 47—53.[CrossRef][Medline] [Order article via Infotrieve]
  • Utzinger J., Bergquist R., Xiao SH, Singer BH, Tanner M. Sustainable schistosomiasis control— the way forward. Lancet 2003; 362: 1932—4.[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by King, C. H.
Right arrow Articles by Dangerfield-Cha, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, C. H.
Right arrow Articles by Dangerfield-Cha, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?